This summer, CCADD welcomes two undergraduate interns, Hyunji Park and Dayoon Lee, for the 2026 Summer Internship Program.

Hyunji Park is an undergraduate student in Bio Nano Engineering at Hanyang University, where she is also pursuing interdisciplinary studies in Pharmaceutical Science and Intelligent Robotics. Her academic interests lie at the intersection of life sciences, artificial intelligence, and digital healthcare, with a particular focus on applying data-driven approaches to drug development and clinical research. She has gained interdisciplinary research experience in molecular biology, proteomics, and biomedical data analysis through projects involving DNA cloning, urine exosome-based biomarker discovery for the early diagnosis of preeclampsia, and machine learning-based proteomic data analysis using OmicLearn. These experiences have strengthened her interest in integrating experimental biology with computational approaches and were recognized with research awards from Hanyang University and the Women's Bioscience Forum. Through the CCADD internship, she hopes to contribute to interdisciplinary research while expanding her understanding of AI-driven drug development and computational approaches for evaluating drug efficacy and safety. She aims to further develop her expertise in biomedical data analysis, translational research, and regulatory science, ultimately contributing to safer and more effective drug development.

Dayoon Lee is an undergraduate student at Seoul National University, where she studies Animal Biotechnology alongside an interdisciplinary major in Artificial Intelligence. Her academic interests lie at the intersection of biomedical science and computational research, particularly in understanding how data-driven methods can support safer and more effective drug development. She has gained interdisciplinary research experience in CAR-T cell engineering, toxicology, and medical AI, including a 3D CT-based Vision-Language Model project conducted in collaboration with clinicians. Through the CCADD internship, she hopes to combine her biological with computational approaches and explore how AI and biomedical data can contribute to evaluating drug efficacy and safety. She aims to strengthen her expertise in data-driven drug development and regulatory science through participation in CCADD’s ongoing research projects.

CCADD warmly welcomes the two interns and hopes that the program will provide them with meaningful opportunities to expand their research experience, deepen their understanding of drug development, and pursue their scientific interests with curiosity and independence.